Progenra, Inc.
PrivateLast Round
Grant
May 16, 2025
Total Funding Raised
$7.81M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Progenra, Inc. is a biotechnology company that develops novel therapeutics targeting the ubiquitin-proteasome system, including molecular glues and targeted protein degradation for neurodegenerative, cardiovascular, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Progenra, Inc. Comparables
Compare Progenra, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SEED Therapeutics | 85% | |
| GluBio Therapeutics | 83% | |
| Dunad Therapeutics | 81% | |
Progenra, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 16, 2025 | ||||
| Grant | Sep 20, 2024 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | May 26, 2020 |
Key People
Founding team and executive leadership
Progenra, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 33% QoQ from 9 to 12 employees.
- Jul 24, 2026
Monthly visitors increased 36% MoM, reaching 2.4K.
Progenra, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Progenra, Inc.'s valuation, stock price, and market status.